Clinical Overview

Bradycardia is a rate-based finding — a confirmed heart rate below 60 beats per minute (bpm) in an adult — not a diagnosis of which rhythm produced it (Desai & Hajouli, StatPearls, Arrhythmias, 2023; Cleveland Clinic, Bradycardia, 2025). The term describes what the rate is doing, and nothing about which pacemaker or conduction pathway is responsible. A slow rate can come from the sinus node itself firing too slowly (sinus bradycardia, the single most common cause), from a subsidiary junctional or ventricular pacemaker taking over once faster impulses stop arriving, or from a high-grade block that prevents some or all atrial impulses from reaching the ventricles (Merck Manual Professional Edition, Overview of Arrhythmias, 2025; Nickson, LITFL, Bradycardia DDx, 2023). Confirming which of those is present requires reading the P-wave morphology and the P-to-QRS relationship on the strip — a generic bradycardia finding does not, by itself, establish that.

In this dataset, records carrying this generic Bradycardia label rarely also carry the more specific Sinus Bradycardia label, and most also carry a co-occurring ST-segment or T-wave finding. That pattern is consistent with this label functioning as a non-specific “the rate is slow” annotation — applied when a reviewer flagged the rate without additionally confirming, or without noting, a sinus origin — rather than as its own distinct rhythm diagnosis. [CLINICAL REVIEW NEEDED: the dataset does not document the rule used to file a strip under this generic label instead of under the sinus-specific one, so this label should not be read as ruling sinus origin in or out for any individual record.]

Some clinical sources use “bradyarrhythmia” as a loose synonym for bradycardia; others define it more narrowly as a slow rate specifically caused by an irregular heartbeat, distinct from bradycardia’s plain rate threshold (Cleveland Clinic, Bradyarrhythmia, 2022). This page follows the narrower, rate-only definition of bradycardia and treats “bradyarrhythmia” as a related but not interchangeable term.

Mechanistically, a slow ventricular rate arises from one of three places in the conduction system: reduced automaticity at the sinus node itself (from high vagal tone or intrinsic sinus node disease), failure of conduction from the atria to the ventricles (AV block), or the emergence of a slower subsidiary escape pacemaker — junctional or ventricular — once the dominant pacemaker’s rate falls below that focus’s own intrinsic firing rate (Desai & Hajouli, 2023; Merck Manual Professional Edition, 2025).

Clinical significance depends entirely on which of those mechanisms is present and on the patient’s tolerance for the resulting rate. Bradycardia is frequently physiologic and benign — a normal finding in trained athletes, during sleep, and in many healthy young adults — but it can also be the first sign of sinus node disease, a high-grade AV block, structural heart disease, a drug effect, or a metabolic derangement, and it is common as a comorbid finding in heart failure (Cleveland Clinic, 2025; Kusumoto et al., 2018 ACC/AHA/HRS Guideline on Bradycardia and Cardiac Conduction Delay, Circulation, 2019).

Many people with bradycardia are asymptomatic, and the finding is often incidental. When symptoms occur, they reflect inadequate cardiac output for the patient’s metabolic demand and include fatigue, exercise intolerance, lightheadedness, dizziness, confusion, presyncope or syncope, dyspnea, and, in more severe cases, chest discomfort; patients themselves rarely perceive the slow rate as a palpitation (Cleveland Clinic, 2025; Merck Manual Professional Edition, 2025).

Causes and risk factors span intrinsic and extrinsic categories. Intrinsic causes include sinus node dysfunction (sick sinus syndrome, often age-related fibrosis), AV block from fibrotic or ischemic conduction-system disease, structural heart disease, and infiltrative or inflammatory disease such as cardiac sarcoidosis or amyloidosis. Extrinsic causes include AV-nodal- and sinus-node-depressant medications (beta-blockers, calcium-channel blockers, digoxin, amiodarone, clonidine, opioids), metabolic derangements (hypothyroidism, hyperkalemia, hypothermia), infections (Lyme disease, endocarditis, Chagas disease), obstructive sleep apnea, elevated intracranial pressure (Cushing reflex), and vagal stimulation (Nickson, 2023; MedlinePlus/NIH, Slow Heart Rate – Bradycardia, 2026).

Interpretation Guide

Key Features:

• Rate below 60 bpm in adults — the single defining feature; the underlying mechanism is not specified by the rate alone
• Rhythm may be regular (sinus bradycardia, junctional escape, or a fixed-ratio AV block) or irregular (sinoatrial block, a variable-ratio AV block, or atrial fibrillation with a slow ventricular response); which one is present must be read from the strip, not assumed from the label (Nickson, 2023)
• P waves: presence, morphology, and relationship to the QRS are the features that actually identify the mechanism — normal and 1:1 with every QRS points to sinus origin; absent, retrograde, or dissociated from the QRS points to a junctional or ventricular escape rhythm; present but only partially conducted points to AV block (Merck Manual Professional Edition, 2025)
• PR interval: normal and constant in sinus bradycardia; progressively lengthening or fixed-but-prolonged in AV block; unrelated to QRS timing when P waves and QRS complexes are dissociated
• QRS complex: narrow in sinus bradycardia and in a junctional escape rhythm with normal conduction; wide when a ventricular escape pacemaker or aberrant conduction is responsible (Burns & Buttner, LITFL ECG Library, Junctional Escape Rhythm, 2025)
• ST segment: not a defining feature of bradycardia itself; evaluate for a coexisting ischemic or metabolic finding
• T waves: not a defining feature of bradycardia itself; evaluate for a coexisting finding
• QT interval: the absolute QT lengthens as rate slows, so assess the rate-corrected QTc rather than the raw QT interval when a slow rate is present
• Other findings: because this is a rate-based, mechanism-agnostic label, the diagnostic task is to identify which specific rhythm (see Differential Diagnosis) is producing the slow rate, not to treat “bradycardia” as a complete rhythm interpretation on its own

Do not stop at “the rate is slow.” Confirm P-wave presence, morphology, and the P-to-QRS relationship before assuming a sinus mechanism — that confirmation is what separates sinus bradycardia from the escape and block rhythms below.

Key Leads

• Lead II – Best lead for assessing P-wave morphology and axis; use it to determine whether an upright, sinus-origin P wave precedes every QRS, or whether P waves are absent, retrograde, or dissociated.
• Lead V1 – A second, independent view of P-wave shape and timing, useful when Lead II’s baseline makes a P wave hard to see, and for judging whether an escape QRS is narrow (junctional) or wide (ventricular) from its morphology.
• This finding is not lead-agnostic: identifying which specific rhythm is producing the slow rate depends on a lead with clearly visible P waves, which Lead II and V1 most reliably provide.

Differential Diagnosis

• Sinus Bradycardia — a confirmed upright P wave precedes every QRS with a constant, normal PR interval, establishing sinus origin; a generic bradycardia call without that confirmation should not be assumed to be sinus in origin.
• Atrioventricular Junctional Rhythm — a junctional escape rhythm at roughly 40-60 bpm with a narrow QRS and P waves that are absent, retrograde, or dissociated from the QRS, unlike the consistent 1:1 sinus P wave of true sinus bradycardia.
• 3 Degree Atrioventricular Block (3AVB) — P waves and QRS complexes march at their own independent rates with no relationship between them (complete AV dissociation), and the ventricular escape rate producing the bradycardia is set by a subsidiary pacemaker below the block, not by the sinus node.
• Sinoatrial Block — intermittently dropped whole P-QRS cycles produce pauses that are multiples of the baseline P-P interval, rather than the uniformly slow, continuously present complexes of a sustained bradycardia.
• Atrioventricular Dissociation — the atria and ventricles are paced independently by two separate pacemakers, which can produce a slow ventricular rate, but the mechanism is dissociation between two competing pacemakers rather than a single slowed or blocked one.

Treatment Brief

Because this label does not specify which mechanism is present, start by reading the strip rather than acting on the label alone: confirm P-wave presence, morphology, and the P-to-QRS relationship, and note whether the QRS is narrow or wide.

Asymptomatic bradycardia, including the physiologic form common in athletes, young adults, and during sleep, generally requires no treatment regardless of how slow the rate is (Cleveland Clinic, 2025).

Monitoring priorities: correlate the rate and rhythm with the clinical context (an athlete at rest versus a patient on a nodal-blocking agent), and check vital signs and mental status for signs of inadequate perfusion once the underlying mechanism is identified.

For symptomatic bradycardia or hemodynamic compromise: notify the provider promptly, obtain a 12-lead ECG, and support the patient per protocol — IV atropine or transcutaneous pacing for unstable patients (Kusumoto et al., 2019; Merck Manual Professional Edition, 2025). Review the medication list for AV-nodal- or sinus-node-depressant drugs and correct reversible metabolic causes such as hypothyroidism or hyperkalemia. A permanent pacemaker may be indicated for symptomatic bradycardia that persists despite addressing reversible causes, regardless of which specific mechanism is ultimately identified (Cleveland Clinic, 2025; Kusumoto et al., 2019).